MedTrace Logo

Treatment of Social Phobia

NCT00000370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-01-18

No results posted yet for this study

Summary

Social phobia is a very common and debilitating disorder, with public speaking anxiety being the most common fear. Psychologists have found that treating patients for their fear of public speaking, through cognitive-behavioral treatment (talk-based therapy) or exposure treatment (where participants participate in actual public speaking sessions), not only helps patients overcome this fear but also helps them overcome their more general social fears. However, little is known about how this change occurs during therapy. This study tries to identify the factors that contribute most to successful therapy.

Patients are assigned randomly (like tossing a coin) to 1 of 3 groups. Group 1 will receive cognitive-behavioral treatment and Group 2 will receive exposure treatment. Group 3 will not receive treatment. Study leaders will monitor patient response to treatment through behavioral tests and assessments.

An individual may be eligible for this study if he/she:

Has social phobia with public speaking anxiety.

Conditions

  • Phobic Disorders
  • Social Phobia
  • Public Speaking Anxiety

Interventions

BEHAVIORAL

Cognitive behavior therapy

BEHAVIORAL

Performance-based exposure therapy

BEHAVIORAL

Psychosocial intervention

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Boston University Charles River Campus

    lead OTHER

Principal Investigators

  • Stefan Hofmann, PhD

Study Design

Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Completion
2003-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000370 on ClinicalTrials.gov